Showing results (931-940 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|February 4, 2021
Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12Qingxiang Li, Yuke Li, Yifei Wang, et al.
Oncoimmunology|February 4, 2021
Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapyPeng Bai, Yongzheng Li, Qiuping Zhou, et al.
Oncoimmunology|February 4, 2021
Characterization of CD8+ T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutionsTomoyo Shinkawa, Serina Tokita, Munehide Nakatsugawa, et al.
Oncoimmunology|January 10, 2022
T and NK cell abundance defines two distinct subgroups of renal cell carcinomaMoon Hee Lee, Petrus Järvinen, Harry Nísen, et al.
Oncoimmunology|January 10, 2022
Association between immune-related adverse event timing and treatment outcomesDavid Hsiehchen, Abdul Rafeh Naqash, Magdalena Espinoza, et al.
Oncoimmunology|January 30, 2014
NK-cell fratricide: Dynamic crosstalk between NK and cancer cellsKyohei Nakamura, Masafumi Nakayama, Mitsuko Kawano, et al.
Oncoimmunology|May 31, 2019
Interleukin-1β provided by KIT-competent mast cells is required for KRAS-mutant lung adenocarcinomaIoannis Lilis, Giannoula Ntaliarda, Vassilios Papaleonidopoulos, et al.
Oncoimmunology|May 31, 2019
Impaired circulating myeloid CD1c+ dendritic cell function in human glioblastoma is restored by p38 inhibition - implications for the next generation of DC vaccinesJason Adhikaree, Hester Ann Franks, Constantinos Televantos, et al.
Oncoimmunology|May 31, 2019
Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cellsMaria C Ochoa, Elisabeth Perez-Ruiz, Luna Minute, et al.
Oncoimmunology|March 17, 2022
Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancerKathleen Ducoin, Romain Oger, Linda Bilonda Mutala, et al.
Pageof 379